Purchase Order 75N91020P00076

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on August 8, 2019, with a ceiling value of $18,641.70 for firm fixed price procurement. The place of performance is Bethesda, Maryland 20814. No set-aside category was applied. The order ultimate completion date is August 7, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on April 17, 2018, for $6,222.68 with an ultimate completion date of May 26, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific goods or services procured are not described in the source documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 27, 2018, with a ceiling value of $7,422.68. The order, issued under firm fixed pricing, calls for delivery to Bethesda, Maryland, with an ultimate completion date of July 8, 2019. No set-aside was applied.</p>

The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC valued at $17,871.00 on February 1, 2018, with an ultimate completion date of January 31, 2019. The order carries fixed-price pricing with economic price adjustment and covers scientific equipment and consumables to be delivered to Bethesda, Maryland. Global Life Sciences Solutions is a wholly owned subsidiary of Danaher Corporation and competes full-and-open without small business set-asides.

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $14,350.00 on November 17, 2019, covering the service renewal of a Delta Vision Elite service contract. Work is performed in Bethesda, Maryland. The order carried a firm fixed price and was set to complete on November 16, 2020. No set-aside category applied.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Government Scientific Source Inc., a small business, valued at $14,877.85 on July 18, 2017. Performance is located in Bethesda, Maryland. The order was issued under firm fixed pricing with no set-aside category. Ultimate completion is scheduled for December 31, 2017.</p>